Dynamics of changes in self-efficacy and locus of control expectancies in the behavioral and drug treatment of severe migraine

Annals of Behavioral Medicine

Volumn 40, Issue 3, 2010, Pages 235-247

  Seng, Elizabeth K ^a   Holroyd, Kenneth A ^a  

^a OHIO UNIVERSITY   (United States)

Author keywords

Behavioral treatment; Drug treatment; Locus of control; Migraine; Self efficacy; Socioeconomic status

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; PROPRANOLOL;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; METHODOLOGY; MIDDLE AGED; MIGRAINE; PATIENT SATISFACTION; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SELF CONCEPT; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; ADULT; ANALYSIS OF VARIANCE; CHI-SQUARE DISTRIBUTION; COGNITIVE THERAPY; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INTERNAL-EXTERNAL CONTROL; MIDDLE AGED; MIGRAINE DISORDERS; PATIENT SATISFACTION; PROPRANOLOL; QUALITY OF LIFE; QUESTIONNAIRES; SELF EFFICACY; TREATMENT OUTCOME;

EID: 78649330125     PISSN: 08836612     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12160-010-9223-3     Document Type: Article

References (58)

1. Y Nestoriuc A Martin 2007 Efficacy of biofeedback for migraine: A meta-analysis Pain 128 111 127 10.1016/j.pain.2006.09.007 17084028 (Pubitemid 46216605)
2. D Penzien J Rains F Andrasik 2002 Behavioral management of recurrent headache: Three decades of experience and empiricism Appl Psychophysiol Biofeedback 27 163 181 10.1023/A:1016247811416 12206049 (Pubitemid 34848001)
3. Campbell J, Penzien D, Wall E: Evidence-based guidelines for migraine headache: Behavioral and physical treatments. American Academy of Neurology Guidelines 2000. Retrieved May 03, 2010, from www.aan.com/professionals/ practice/pdfs/gl0089.pdf
4. K Holroyd D Penzien 1990 Pharmacological vs. nonpharmacological prophylaxis of recurrent migraine headache: A meta-analytic review of clinical trials Pain 42 1 13 10.1016/0304-3959(90)91085-W 2146583 1:STN:280: DyaK3M%2FksVCntQ%3D%3D (Pubitemid 20231771)
5. S Silberstein 2000 Practice Parameter: Evidence-based guidelines for migraine headache (an evidence-based review) Neurology 55 754 762 10993991 1:CAS:528:DC%2BD3cXntlygsLg%3D
6. A Bandura 1977 Self-efficacy: Toward a unifying theory of behavioral change Psychol Rev 84 191 215 10.1037/0033-295X.84.2.191 847061 1:STN:280:DyaE2s7kvFCisQ%3D%3D
7. Bandura A: Self-efficacy: The exercise of control. New York: W.H. Freeman, 1997.
8. JB Rotter 1966 Generalized expectancies for internal versus external control of reinforcement Psychol Monogr 80 1 28 5340840 1:STN:280: DyaF2s3htlGrsA%3D%3D
9. T Bodenheimer K Lorig H Holman K Grumbach 2002 Patient self management of chronic disease in primary care JAMA 288 2469 2475 10.1001/jama.288.19.2469 12435261 (Pubitemid 35340544)
10. R Marks J Allegrante K Lorig 2005 A review and synthesis of research evidence for self-efficacy-enhancing interventions for reducing chronic disability: Implications for health education practice Health Promote Pract 6 37 43 10.1177/1524839904266790
11. Tobin D, Reynolds R, Holroyd K, Creer T: Self-management and social learning theory. In K. Holroyd and T. Creer (eds), Self-management of chronic disease: Handbook of clinical interventions and research. New York: Academic Press, 1986.
12. J Rains D Penzien G Lipchik 2006 Behavioral facilitation of medical treatment for headache part II: Theoretical models and behavioral strategies for improving adherence Headache 46 1395 1403 10.1111/j.1526-4610.2006.00582.x 17040336 (Pubitemid 44556430)
13. RA Nicholson RG Hursey JM Nash 2005 Moderators and mediators of behavioral treatment for headache Headache 45 513 519 10.1111/j.1526-4610.2005. 05103.x 15953268 (Pubitemid 40847174)
14. Holroyd K, Penzien D, Rains J, Lipchik G, Buse D: Behavioral management of headaches. In S. Silberstein, R. Lipton and D. Dodick (eds), Wolff's Headache and Other Head Pain. New York, NY: Oxford University Press, 2008, 721-746.
15. Holroyd K, Martin P: Psychological treatments for tension-type headache. In J. Olesen, P. Tfelt-Hansen and K. Welch (eds), The headaches. Philadelphia: Lippincott Williams & Wilkins, 2000, 643-649.
16. DJ French KA Holroyd C Pinnell, et al. 2000 Perceived self-efficacy and headache-related disability Headache 40 647 656 10.1046/j.1526-4610.2000. 040008647.x 10971661 1:STN:280:DC%2BD3M%2Fnt1Kktg%3D%3D
17. KA Holroyd J Labus BW Carlson 2009 Moderation and mediation in the psychological and drug treatment of chronic tension-type headache: The role of disorder severity and psychiatric comorbidity Pain 143 213 222 10.1016/j.pain.2009.02.019 19342174
18. LA Rokicki KA Holroyd CR France, et al. 1997 Change mechanisms associated with combined relaxation/EMG biofeedback training for chronic tension headache Appl Psychophysiol Biofeedback 22 21 41 10.1023/A:1026285608842 9287253 1:STN:280:DyaK2svjt1GrtQ%3D%3D
19. Y Nestoriuc W Rief A Martin 2008 Meta-analysis of biofeedback for tension-type headache: Efficacy, specificity, and treatment moderators J Consult Clin Psychol 76 379 396 10.1037/0022-006X.76.3.379 18540732 (Pubitemid 351822339)
20. KA Holroyd PT Malinoski BW Carlson 2002 Patient characteristics and treatment adherence predict response to antidepressant medication and to cognitive-behavior therapy for chronic tension-type headache Ann. Behav. Med 24 S050
21. R Nicholson J Nash 2005 Andrasik: A self-administered behavioral intervention using tailored messages for migraine Headache 45 1124 1139 10.1111/j.1526-4610.2005.00236.x 16178943 (Pubitemid 350004902)
22. BE Thorn LB Pence LC Ward, et al. 2007 A randomized clinical trial of targeted cognitive behavioral treatment to reduce catastrophizing in chronic headache sufferers J Pain 8 938 949 10.1016/j.jpain.2007.06.010 17690017 (Pubitemid 350161437)
23. D Mizener M Thomas R Billings 1988 Cognitive changes of migraineurs receiving biofeedback training Headache 28 339 343 10.1111/j.1526-4610.1988. hed2805339.x 3403252 1:STN:280:DyaL1c3pvVWqsA%3D%3D
24. S Lee J Park M Kim 2005 Efficacy of the 5-HT1A agonist, buspirone hydrochloride, in migraineurs with anxiety: A randomized, prospective, parallel group, double-blind, placebo-controlled study Headache 45 7 10.1111/j.1526-4610. 2005.05181.x
25. NJ Martin KA Holroyd DB Penzien 1990 The headache-specific locus of control scale: Adaptation to recurrent headaches Headache 30 729 734 10.1111/j.1526-4610.1990.hed3011729.x 2074167 1:STN:280:DyaK3M7mtFehsA%3D%3D
26. KA Wallston 2005 The Validity of the Multidimensional Health Locus of Control Scales J Health Psychol 10 623 631 10.1177/1359105305055304 16033784 (Pubitemid 41192347)
27. RA Nicholson TT Houle JL Rhudy PJ Norton 2007 Psychological Risk Factors in Headache Headache 47 413 426 17371358
28. SD Hollon J DeRubeis 1981 Placebo-psychotherapy combinations: Inappropriate representations of psychotherapy in drug-psychotherapy comparative trials Psychol Bull 90 467 477 10.1037/0033-2909.90.3.467 7029596 1:STN:280:DyaL38%2FmtV2jsw%3D%3D
29. DJ Cox A Freundlich RG Meyer 1975 Differential effectiveness of electromyograph feedback, verbal relaxation instructions, and medication placebo with tension headaches J Consult Clin Psychol 43 892 898 10.1037/0022-006X.43. 6.892 1104671 1:STN:280:DyaE28%2FmvFylsw%3D%3D
30. SM Sotsky DR Glass MT Shea PA Pilkonis, et al. 1991 Patient predictors of response to psychotherapy and pharmacotherapy: Findings in the NIMH Treatment of Depression Collaborative Research Program Am J Psychiatry 148 997 1008 1853989 1:STN:280:DyaK3MzgslSmsw%3D%3D
31. Holroyd K, Cottrell C, O'Donnell F, et al.: Does Preventive (Beta Blocker) Medication, Behavioral Migraine Management or Their Combination Improve Outcomes of Optimal Acute Therapy in Frequent Migraine: A Randomized Trial. Submitted.
32. K Holroyd C Cottrell F O'Donnell, et al. 2006 Does preventive medication, behavioral migraine management or their combination add to optimal acute therapy in the management of frequent migraines: The TSM trial Headache 46 835
33. Headache Classification Committee of the International Headache Society 1988 Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain Cephalalgia 8 1 96 10.1046/j.1468-2982.1988.0801001.x (Pubitemid 18091138)
34. Holroyd K, Cottrell C, Echelberger-McCune R: Behavioral management for migraine headaches: A treatment program. Athens, OH: Ohio University Headache Treatment and Research Project, 2000.
35. P Jhingran JT Osterhouse DW Miller JT Lee L Kirchdoerfer 1998 Development and validation of the migraine-specific quality of life questionnaire Headache 38 295 302 10.1046/j.1526-4610.1998.3804295.x 9595870 1:STN:280: DyaK1c3lvVagtg%3D%3D
36. BD Heckman KA Holroyd G Tietjen, et al. 2009 Whites and African-Americans in headache specialty clinics respond equally well to treatment Headache 29 650 661 1:STN:280:DC%2BD1MjislSjtg%3D%3D
37. DR Williams C Collins 1995 US socioeconomic and racial differences in health: Patterns and explanations Annu Rev Sociol 21 349 10.1146/annurev.so.21. 080195.002025
38. AC Leon CH Mallinckrodt C Chuang-Stein D Archibald G Archer K Chartier 2006 Attrition in randomized controlled clinical trials: Methodological issues in pyschopharmacology Biol Psychiatry 59 1001 1005 10.1016/j.biopsych.2005.10. 020 16503329 (Pubitemid 43870057)
39. C Mallinckrodt W Clark S David 2001 Accounting for dropout bias using mixed-effects models J Biopharm Stat 11 9 21 10.1081/BIP-100104194 11459446 1:STN:280:DC%2BD38%2FitlSquw%3D%3D (Pubitemid 32642825)
40. C Mallinckrodt W Clark S David 2001 Type I error rates from mixed-effects model repeated measures versus fixed effects ANOVA with missing values imputed via last observation carried forward Drug Inf J 35 1215 1225
41. C Mallinckrodt T Sanger S Dube, et al. 2003 Assessing treatment effects in longitudinal data Biol Psychiatry 53 754 760 10.1016/S0006-3223(02)01867-X 12706959 (Pubitemid 39658489)
42. G Molenberghs H Thijs I Jansen C Beunckens 2004 Analyzing incomplete longitudinal clinical trial data Biostatistics 5 445 464 10.1093/biostatistics/ kxh001 15208205 (Pubitemid 41180218)
43. S Barnes C Mallinckrodt S Lindborg M Carter 2008 The impact of missing data and how it is handled on the rate of false-positive results in drug development Pharm Statist 7 215 225 10.1002/pst.310
44. G Gadbury C Coffey D Allison 2003 Modern statistical methods for handling missing data Obes Rev 4 175 184 10.1046/j.1467-789X.2003.00109.x 12916818 1:STN:280:DC%2BD3szotVymsQ%3D%3D (Pubitemid 36950579)
45. Lipchik G, Holroyd K, Nash J: Cognitive-behavioral management of recurrent headache disorders: A minimal-therapist contact approach. In D. Turk and R. Gatchel (eds), Psychological Approaches to Pain Management. New York, NY: Guilford Press, 2002, 356-389.
46. R Lipton M Bigal M Diamond, et al. 2007 Migraine prevalence, disease burden, and the need for preventive therapy Neurology 68 343 349 10.1212/01.wnl.0000252808.97649.21 17261680 1:STN:280:DC%2BD2s%2FlslCgsg%3D%3D (Pubitemid 46184209)
47. Link BG, Phelan J: Social conditions as fundamental causes of disease. J Health Soc Behav. 1995, Spec No:80-94.
48. J Brandes 2008 The migraine cycle: Patient burden of migraine during and between migraine attacks Headache 48 430 441 10.1111/j.1526-4610.2007.01004.x 18179565 (Pubitemid 351517765)
49. Silberstein S, Freitag F, Bigal M: Migraine treatment. In S. Silberstein, R. Lipton and D. Dodick (eds), Wolff's Headache and Other Head Pain. London: Oxford University Press, 2008, 177-292.
50. Ramadan N, Silberstein S, Freitag F, Gilbert T, Frishberg B: Evidence-based guidelines for migraine headache in the primary care setting: Pharmacological management for the prevention of migraine. American Academy of Neurology Guidelines 2002. Retrieved Accessed May 03 2010, from http://www.aan.com/professionals/practice/pdfs/gl0090.pdf
51. T Steiner K Paemeiere RVD Jensen, et al. 2007 European principles of management of common headache disorders in primary care J Headache Pain 8 S3 47 10.1007/s10194-007-0353-8 18034215 (Pubitemid 46443506)
52. pt?>Kaniecki RL, S: Treatment of primary headache: Preventive treatment of migraine. Standards of care for headache diagnosis and treatment. Chicago: National Headache Foundation, 2004, 40-52.
53. J Brandes J Saper M Diamond, et al. 2004 Topiramate for migraine prevention JAMA 291 965 973 10.1001/jama.291.8.965 14982912 1:CAS:528: DC%2BD2cXhs1ejtbc%3D (Pubitemid 38543754)
54. S Silberstein W Neto J Schmitt D Jacobs 2004 Topiramate in migraine prevention: Results of a large controlled trial Arch Neurol 61 490 495 10.1001/archneur.61.4.490 15096395 (Pubitemid 38923736)
55. H-C Diener P Tfelt-Hansen C Dahlof, et al. 2004 Topiramate in migraine prophylaxis: Results from a placebo-controlled trial with propranolol as an active control J Neurol 251 943 950 10.1007/s00415-004-0464-6 15316798 1:CAS:528:DC%2BD2cXosVSrtLc%3D
56. DJ French JG Gauthier C Roberge A Nouwen 1997 Self-efficacy in the thermal biofeedback treatment of migraine sufferers Beh Ther 28 109 125 10.1016/S0005-7894(97)80037-8 (Pubitemid 27319038)
57. KA Holroyd DB Penzien K Hursey, et al. 1984 Change mechanisms in EMG biofeedback training: Cognitive changes underlying improvements in tension headache J Consult Clin Psychol 52 1039 1053 10.1037/0022-006X.52.6.1039 6520274 1:STN:280:DyaL2M7gsFOisA%3D%3D
58. EB Blanchard M Kim C Hermann, et al. 1994 The role of perception of success in the thermal biofeedback treatment of vascular headache Headache Q 5 231 236